Promising Effects of Montelukast for Critically Ill Asthma Patients via a Reduction in Delirium
<b>Background:</b> Montelukast (MTK), a potent antagonist of cysteinyl leukotriene receptor 1, has shown therapeutic promise for the treatment of neuropsychiatric disorders. Delirium, a common complication in critically ill patients, lacks effective treatment. This study aims to explore the impact o...
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI AG
2024-01-01
|
| Series: | Pharmaceuticals |
| Assuntos: | |
| Acceso en liña: | https://www.mdpi.com/1424-8247/17/1/125 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|